Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology Appraisal-Reference-Cited by-同舟云学术

Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Published:2018-12-13 Issue:9 Volume:37 Page:1073-1080
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Ren Shijie^ORCID,Squires Hazel,Hock Emma,Kaltenthaler Eva,Rawdin Andrew,Alifrangis Constantine

Funder

National Institute for Health Research

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40273-018-0750-2.pdf

Reference18 articles.

1. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. 2013 [cited 15 Jun 2018]. https://www.nice.org.uk/process/pmg9 . Accessed 15 June 2018.

2. Ren S, Squires H, Kaltenthaler E, Hock E, Rawdin A, Clowes M, et al. Pembrolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable. 2018 [cited 15 Jun 2018]. https://www.nice.org.uk/guidance/ta522 . Accessed 15 June 2018.

3. National Institute for Health and Care Excellence. Pembrolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable. 2018 [cited 15 Jun 2018]. https://www.nice.org.uk/guidance/ta522 . Accessed 15 June 2018.

4. Eble J, Sauter G, Epstein J, Sesterhenn I. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. WHO Classification of Tumours. International Agency for Research on Cancer; 2004. p. 7.

5. Cancer Research UK. Bladder Cancer, Types, Stages and grades. 2016 [cited 15 Jun 2018]. http://about-cancer.cancerresearchuk.org/about-cancer/bladder-cancer/types-stages-grades/types . Accessed 15 June 2018.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A metachronous bilateral upper urinary tract urothelial carcinoma achieved partial remission by multiple treatment modalities: A case report and literature review;2023-11-14

2. Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative review;Current Urology;2023-05-05

3. Combination toripalimab and bevacizumab for an elderly urothelial carcinoma patient with brain metastasis who failed rapidly after radiotherapy: a case report and literature review;Anti-Cancer Drugs;2022-10-24

4. Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost–effectiveness analysis;Journal of Comparative Effectiveness Research;2022-10

5. Parametric G‐computation for compatible indirect treatment comparisons with limited individual patient data;Research Synthesis Methods;2022-05-16